• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物预处理稳定型心绞痛患者冠状动脉介入治疗相关心肌梗死的预测因素。

Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins.

机构信息

Department of Cardiology, 2 Medical School, Charles University, University Hospital Motol, Prague, Czech Republic.

出版信息

Arch Med Sci. 2011 Feb;7(1):67-72. doi: 10.5114/aoms.2011.20606. Epub 2011 Mar 8.

DOI:10.5114/aoms.2011.20606
PMID:22291735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3258701/
Abstract

INTRODUCTION

Peri-procedural myocardial infarction (PMI) is a frequent and prognostically important complication of percutaneous coronary intervention (PCI). This study was designed to determine the predictors of PMI in patients pre-treated with statins.

MATERIAL AND METHODS

A total of 418 stable angina pectoris patients taking statins and aspirin were included. All the patients underwent PCI. Serum concentrations of creatine kinase (CK-MB mass) and troponin I (TnI) were measured prior to and then within 16 to 24 hours after PCI. The incidence of PMI was assessed using the established criteria (≥ 3 times upper limit of normal).

RESULTS

Four hundred and eighteen stable patients (63 ±10 years, 68% males) were treated by PCI. The technical success rate of PCI was 99%. The incidence of PMI based on CK-MB mass or TnI release was 12% (PMI group). There were no significant differences in baseline clinical and procedural characteristics between PMI and non-PMI groups except for the balloon inflation time (40 ±44 s vs. 26 ±27 s; p = 0.02) and the proportion of treated type C lesions (42% vs. 28%; p = 0.03). In multivariate analysis, the independent predictors of PMI were balloon inflation time (OR = 1.01; 95% CI 1.001-1.020; p = 0.02) and pre-procedural level of C-reactive protein (OR = 1.38; 95% CI 1.059-1.808; p = 0.02).

CONCLUSIONS

These results suggest that C-reactive protein and balloon ischaemic time are independent predictors of PMI in stable angina patients pre-treated with statins.

摘要

引言

经皮冠状动脉介入治疗(PCI)围手术期心肌梗死(PMI)是一种常见且具有重要预后意义的并发症。本研究旨在确定接受他汀类药物预处理的患者发生 PMI 的预测因素。

材料和方法

共纳入 418 例稳定型心绞痛且正在服用他汀类药物和阿司匹林的患者。所有患者均接受 PCI 治疗。PCI 术前和术后 16 至 24 小时内测量肌酸激酶同工酶(CK-MB 质量)和肌钙蛋白 I(TnI)的血清浓度。采用既定标准(≥正常值上限的 3 倍)评估 PMI 的发生率。

结果

418 例稳定型患者(63 ±10 岁,68%为男性)接受 PCI 治疗。PCI 的技术成功率为 99%。根据 CK-MB 质量或 TnI 释放,PMI 的发生率为 12%(PMI 组)。PMI 组与非 PMI 组在基线临床和手术特征方面无显著差异,仅球囊扩张时间(40 ±44 s 比 26 ±27 s;p = 0.02)和处理 C 型病变的比例(42%比 28%;p = 0.03)不同。多变量分析显示,PMI 的独立预测因素为球囊扩张时间(OR = 1.01;95%CI 1.001-1.020;p = 0.02)和术前 C 反应蛋白水平(OR = 1.38;95%CI 1.059-1.808;p = 0.02)。

结论

这些结果表明,C 反应蛋白和球囊缺血时间是稳定型心绞痛患者接受他汀类药物预处理后发生 PMI 的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c3/3258701/6c0b24160dc0/AMS-7-1-67_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c3/3258701/09156a4175ad/AMS-7-1-67_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c3/3258701/6c0b24160dc0/AMS-7-1-67_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c3/3258701/09156a4175ad/AMS-7-1-67_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c3/3258701/6c0b24160dc0/AMS-7-1-67_F2.jpg

相似文献

1
Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins.他汀类药物预处理稳定型心绞痛患者冠状动脉介入治疗相关心肌梗死的预测因素。
Arch Med Sci. 2011 Feb;7(1):67-72. doi: 10.5114/aoms.2011.20606. Epub 2011 Mar 8.
2
Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.阿托伐他汀两日预处理对择期经皮冠状动脉介入治疗后围手术期心肌梗死发生率的影响:一项单中心、前瞻性随机研究。
Am J Cardiol. 2009 Sep 1;104(5):630-3. doi: 10.1016/j.amjcard.2009.04.048. Epub 2009 Jun 24.
3
β-blocker use before elective percutaneous coronary intervention as a risk factor for periprocedural myocardial injury incidence in male patients below 75 years old: a single-center retrospective study.β受体阻滞剂在择期经皮冠状动脉介入治疗前的使用与 75 岁以下男性患者围手术期心肌损伤发生率的相关性:一项单中心回顾性研究。
Ann Palliat Med. 2021 May;10(5):5055-5068. doi: 10.21037/apm-20-2355. Epub 2021 May 14.
4
Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.长期接受他汀类药物治疗的患者,在经皮冠状动脉介入治疗前给予七天阿托伐他汀预处理对围手术期心肌梗死发生率的影响:一项随机研究。
Int J Cardiol. 2013 Oct 3;168(3):2494-7. doi: 10.1016/j.ijcard.2013.03.002. Epub 2013 Apr 15.
5
[Value of index of microcirculatory resistance for early prediction of periprocedural myocardial microcirculatory injury after percutaneous coronary intervention in patients with coronary heart disease].[微循环阻力指数对冠心病患者经皮冠状动脉介入治疗围手术期心肌微循环损伤早期预测的价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):894-900. doi: 10.3760/cma.j.issn.0253-3758.2019.11.008.
6
A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.紫杉醇涂层球囊与药物洗脱支架治疗初发冠状动脉病变时围手术期心肌梗死的比较
Yonsei Med J. 2017 Jan;58(1):99-104. doi: 10.3349/ymj.2017.58.1.99.
7
Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.经皮冠状动脉介入治疗前冠状动脉内应用尼可地尔对稳定型和不稳定型心绞痛患者围术期心肌梗死的影响。
J Cardiol. 2013 Aug;62(2):77-81. doi: 10.1016/j.jjcc.2013.03.017. Epub 2013 Jun 2.
8
Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis.在无提示心肌坏死的临床及操作迹象的患者中,进行无并发症的择期经皮冠状动脉介入治疗后血清肌钙蛋白水平升高。
Postepy Kardiol Interwencyjnej. 2016;12(1):41-8. doi: 10.5114/pwki.2016.56948. Epub 2016 Feb 11.
9
Association of periprocedural myocardial infarction with long-term survival in patients treated with coronary revascularization therapy of chronic total occlusion.慢性完全闭塞病变冠状动脉血运重建治疗患者围手术期心肌梗死与长期生存的关系
Catheter Cardiovasc Interv. 2016 May;87(6):1042-9. doi: 10.1002/ccd.26286. Epub 2015 Nov 3.
10
Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.经皮冠状动脉介入治疗前使用他汀类药物:对围手术期心肌梗死的影响。
Eur Heart J. 2004 Oct;25(20):1822-8. doi: 10.1016/j.ehj.2004.07.017.

引用本文的文献

1
Comparison between In-Hospital and Out-of-Hospital Acute Myocardial Infarctions: Results from the Regional Myocardial Infarction Registry of Saxony-Anhalt (RHESA) Study.院内与院外急性心肌梗死的比较:来自萨克森-安哈尔特州区域性心肌梗死登记研究(RHESA)的结果
J Clin Med. 2023 Sep 29;12(19):6305. doi: 10.3390/jcm12196305.
2
Efficacy and safety of a biodegradable polymer sirolimus-eluting stent in primary percutaneous coronary intervention: a randomized controlled trial.在初次经皮冠状动脉介入治疗中,生物可降解聚合物西罗莫司洗脱支架的疗效和安全性:一项随机对照试验。
Arch Med Sci. 2013 Dec 30;9(6):1040-8. doi: 10.5114/aoms.2013.39793. Epub 2013 Dec 26.
3

本文引用的文献

1
C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation.C反应蛋白与药物洗脱支架植入术后支架血栓形成及心血管事件风险
Circulation. 2009 Nov 17;120(20):1987-95. doi: 10.1161/CIRCULATIONAHA.109.876763. Epub 2009 Nov 2.
2
Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.阿托伐他汀两日预处理对择期经皮冠状动脉介入治疗后围手术期心肌梗死发生率的影响:一项单中心、前瞻性随机研究。
Am J Cardiol. 2009 Sep 1;104(5):630-3. doi: 10.1016/j.amjcard.2009.04.048. Epub 2009 Jun 24.
3
Effect of statins on platelet function in patients with hyperlipidemia.
他汀类药物对高血脂患者血小板功能的影响。
Arch Med Sci. 2013 Aug 30;9(4):622-8. doi: 10.5114/aoms.2013.36905. Epub 2013 Aug 8.
4
Examination of serum pregnancy-associated plasma protein A clinical value in acute coronary syndrome prediction and monitoring.检测血清妊娠相关血浆蛋白 A 在急性冠脉综合征预测和监测中的临床价值。
Arch Med Sci. 2013 Feb 21;9(1):14-20. doi: 10.5114/aoms.2013.33343.
5
The time has come to move from coronary angiography to physiological assessment of coronary lesions.从冠状动脉造影转向冠状动脉病变的生理评估的时候到了。
Arch Med Sci. 2013 Feb 21;9(1):1-2. doi: 10.5114/aoms.2013.33342.
Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
新型预防或限制事件(那不勒斯) II 试验方法:阿托伐他汀单次高负荷剂量对围手术期心肌梗死的影响。
J Am Coll Cardiol. 2009 Dec 1;54(23):2157-63. doi: 10.1016/j.jacc.2009.07.005. Epub 2009 Aug 6.
4
Spelling out risk reduction strategies for intracoronary stenting.
EuroIntervention. 2008 Mar;3(5):622-6. doi: 10.4244/eijv3i5a111.
5
High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.高高密度脂蛋白胆固醇可降低择期经皮冠状动脉介入治疗患者经皮冠状动脉介入治疗相关心肌梗死的风险和程度,并改善其长期预后。
Eur Heart J. 2009 Aug;30(15):1894-902. doi: 10.1093/eurheartj/ehp183. Epub 2009 May 27.
6
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
7
Universal definition of myocardial infarction.心肌梗死的通用定义。
Eur Heart J. 2007 Oct;28(20):2525-38. doi: 10.1093/eurheartj/ehm355.
8
Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.阿托伐他汀对高胆固醇血症患者急性全身炎症诱导的内皮功能障碍的保护作用。
Eur Heart J. 2007 Sep;28(17):2102-9. doi: 10.1093/eurheartj/ehm247. Epub 2007 Jun 27.
9
Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.降胆固醇治疗对C反应蛋白的低密度脂蛋白依赖性和非依赖性影响:一项荟萃分析。
J Am Coll Cardiol. 2007 May 22;49(20):2003-9. doi: 10.1016/j.jacc.2007.01.083. Epub 2007 May 4.
10
Serial measurements of C-reactive protein after acute myocardial infarction in predicting one-year outcome.
Int Heart J. 2006 Nov;47(6):833-42. doi: 10.1536/ihj.47.833.